Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
GENBthis companyGenerate Biomedicines, Inc.	$13.88	-2.54×	-1.03×	19.87×	-2.78×	-546.2%	100.0%	-737.0%	-637.0%	33.0%	-89.4%	-32.2%	-0.11×	0.25×	-206.92×	2.85×	0.0%	—	—	1	C-
ABSIAbsci Corporation	$11.05	-4.15×	2.52×	170.48×	-4.48×	-99.6%	-319.4%	-4454.2%	-4113.7%	-60.8%	-63.6%	-19.7%	0.03×	0.14×	-596.74×	6.57×	0.0%	4	39.57	1	C-
INBXInhibrx Biosciences Inc.	$90.97	-8.74×	153.07×	941.13×	-9.62×	-99.0%	-91.0%	-10386.5%	-10773.5%	-1752.2%	-117.4%	-10.6%	13.39×	0.14×	-11.07×	3.93×	0.0%	3	-1.53	2	C
STROSutro Biopharma, Inc.	$10.50	-0.51×	-0.74×	0.96×	-0.38×	-557.0%	92.9%	-102.4%	-186.5%	144.3%	-98.5%	-182.0%	-0.12×	0.29×	-2.75×	2.01×	0.0%	3	-8.69	2	C
Peer median	—	-4.15×	2.52×	170.48×	-4.48×	-99.6%	-91.0%	-4454.2%	-4113.7%	-60.8%	-98.5%	-19.7%	0.03×	0.14×	-11.07×	3.93×	0.0%	3	-1.53	2	—